Advanced Search

Atopic Dermatitis & Other Forms of Eczema Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Thomas Bieber

    Thomas Bieber

    Department of Dermatology, University of Bonn, Bonn, Germany

  • Photo of Jon Hanifin

    Jon Hanifin

    Department of Dermatology, Oregon Health Sciences University, Portland, OR, USA

Section Topics

  • » Allergic contact dermatitis
  • » Atopic eczema
  • » Contact urticaria
  • » Eczema vaccinatum
  • » Hand eczema
  • » Irritant contact dermatitis
  • » Nummular eczema
  • » Seborrheic eczema
  • » Stasis dermatitis

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

12
The intraepithelial T cell response to NKG2D-ligands links lymphoid stress surveillance to atopy.

Strid J, Sobolev O, Zafirova B, Polic B, Hayday A. Science. 2011 Dec 2; 334(6060):1293-7

2 Evaluations, most recent by

Jakub Tolar and Michael Weinreich, University of Minnesota, USA. F1000 Hematology

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.